September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In this first episode, we speak with Michael Lynch, MD, associate professor of emergency medicine at the University of Pittsburgh and an attending emergency physician and medical toxicologist at the University of Pittsburgh Medical Center.
To help celebrate and recognize National Recovery Month, we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our first episode and our discussion with Michael Lynch, MD, associate professor of emergency medicine at the University of Pittsburgh and an attending emergency physician and medical toxicologist at the University of Pittsburgh Medical Center.
In our conversation, Dr. Lynch addresses what happens when an individual overdoses and what substances beyond fentanyl may be to blame for high rates of opioid use disorder. He also speaks to potential reasons behind the excessive overdose mortality rate in Pennsylvania—in 2022, the state came in at #4 for drug overdose mortality in the US—shares his thoughts on OTC naloxone, and provides insights from his work with the UPMC Toxicology Telemedicine Bridge Clinic.
We hope you learn something new from this series, and we look forward to bringing you future episodes. Please tune in each Monday in September for a new episode drop.
Listen above or on one of these podcast services:
Unlocking Access: Exploring Mental Health Care Among Medicaid Managed Care Enrollees
January 23rd 2025On this episode of Managed Care Cast, we speak with the author of a study published in the January 2025 issue of The American Journal of Managed Care® to examine the association between quantitative network adequacy standards and mental health care access among adult Medicaid enrollees.
Listen
Heath Equity & Access Weekly Roundup: January 27, 2025
January 27th 2025Highlights from last week include President Trump's executive orders, the FDA approval of esketamine nasal spray for depression, mental health access through Medicaid Managed Care, the impact of travel time on surgical outcomes, and life expectancy disparities.
Read More